Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOH_2017-06-22_000552Phase 2Not yet recruiting
Phase 2, randomised, open-label trial of chlorhexidine in peri-implantitis (2 arms), sponsored by ד"ר הדר זיגדון. Primary endpoints: Quantitative bacterial level around the implant, Inflammatory mediator level and 2 more. Planned start Feb 2017; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on MOH_2017-06-22_000552.